Nano-diamonds deliver chemo drugs; Lerner Research names stem cell chief;

Cancer Research

A Northwestern University research team has developed a promising nanomaterial-based biomedical device that could be used to deliver chemotherapy drugs locally to sites where cancerous tumors have been surgically removed. Release

A new study has concluded that red wine can cut a smoker's risk for lung cancer. Story

Antisoma has acquired rights to develop and commercialize novel anti-cancer compounds called PPM1D (protein phosphatase magnesium-dependent 1 d) inhibitors. Antisoma release

Stem Cell Research

The Lerner Research Institute at the Cleveland Clinic has recruited Dr. Jeremy Rich to head up its Department of Stem Cell Biology and Regenerative Medicine. Report

StemCells has won a $305,000 grant from the National Institute of Diabetes and Digestive and Kidney Diseases to research and develop a potential cell-based therapeutic for liver disease arising from infection by the hepatitis C virus. StemCells release

Genetics

New genetic technology has revealed that the virus responsible for AIDS dates back to around 1900. Report

A team of European scientists have identified genetic variations that can trigger ulcerative colitis. Story

A new genetic association with the condition age-related macular degeneration (AMD) is reported in an Article published early Online and in an upcoming edition of The Lancet, written by Dr Sarah Ennis and Professor Andrew Lotery, University of Southampton, UK, and colleagues. Report

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.